XML 50 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating activities    
Net income $ 42,876 $ 25,322
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 35,787 38,033
Amortization of intangible and other assets and favorable/unfavorable leases 1,029 1,107
Amortization of long-term prepaid rents 534 667
Amortization of debt issue costs 1,197 1,184
Amortization of deferred revenues, deferred lease incentives and other (2,212) (2,339)
Amortization of accumulated other comprehensive loss related to interest rate swap agreement 988 1,158
Fair value change in interest rate swap agreements not designated as hedges (268)  
Amortization of bond discount 226 206
Impairment of long-lived assets 185 1,015
Share based awards compensation expense 3,315 2,013
Loss on sale of assets and other 836 472
Deferred lease expenses 1,123 780
Deferred income tax expenses (2,358) (4,770)
Equity in income of affiliates (1,790) (2,438)
Tax benefit related to stock option exercises and restricted stock vesting (3,930) 1,854
Distributions from equity investees 2,658 2,420
Changes in assets and liabilities 9,684 (5,642)
Net cash provided by operating activities 97,740 61,042
Investing activities    
Additions to theatre properties and equipment (46,984) (35,769)
Proceeds from sale of theatre properties and equipment 39 485
Investment in DCIP and other (309) (572)
Net cash used for investing activities (61,334) (35,856)
Financing activities    
Proceeds from stock option exercises 2 348
Payroll taxes paid as a result of restricted stock withholdings (2,700) (494)
Dividends paid to stockholders (23,982) (23,897)
Repayments of long-term debt (3,034) (2,709)
Payments on capital leases (2,277) (1,722)
Other (227) (184)
Net cash used for financing activities (32,218) (28,658)
Effect of exchange rate changes on cash and cash equivalents 2,970 1,783
Increase (decrease) in cash and cash equivalents 7,158 (1,689)
Cash and cash equivalents:    
Beginning of period 521,408 464,997
End of period 528,566 463,308
U S
    
Investing activities    
Acquisition of theatres in the U.S. $ (14,080)